Abstract:Earlier this year, the first death in the United States involving a pan-resistant Klebsiella pneumonia was reported in a patient in whom sepsis developed from a surgical site infection [1]. This case highlights the growing importance of antibiotic resistance to surgeons and their patients. In support of the 2017 U.S. Antibiotic Awareness Week [2], members and officers of the Surgical Infection Society (SIS) are championing the proper usage of antibiotic agents and partnering with the centers for Disease Control and Prevention (CDC), the Global Alliance for Infections in Surgery, and the World Society of Emergency Surgery in attempting to elevate each surgeon’s commitment to proper and effective antibiotic stewardship globally. Tools and resources to support this endeavor are available this week on the Society’s web site (www.sisna.org). In this issue of Surgical Infections, Dr. Massimo Sartelli and over 230 experts from 83 different countries provide a global declaration on appropriate use of antimicrobial agents in hospitals worldwide. Within this declaration, the authors succinctly highlight the contribution of antibiotic exposure, misuse, and overuse to antibiotic resistance and outline the fundamental principles of appropriate antibiotic prophylaxis and therapy in surgery. The Surgical Infection Society endorses this document that has been translated into several languages and made available online with the article as open access for all to view (see online supplementary material at www.liebertpub.com/sur). Global action is needed urgently to slow the trend of increasing antibiotic resistance. Proper education of healthcare providers and the general public is needed in addition to the adoption of broader multi-disciplinary stewardship programs to achieve appropriate antimicrobial use. Although antibiotic agents are used for numerous indications beyond those that are surgical, surgeons should not abdicate their responsibility to ensure proper antibiotic use and appropriate stewardship for their patients. Surgeons are best positioned to ensure that their patients receive timely and appropriate antibiotic therapy at the correct dosage with the shortest indicated course and narrowest spectrum [3]. While inter-disciplinary teams can enhance the performance of stewardship programs [4–8], inter-disciplinary involvement should not diffuse the surgeon’s responsibility for the patient’s outcome. Performance issues remain common on both sides of the antibiotic prescribing equation; inadequate spectrum, delayed initiation, and insufficient dosing regimens on one side and excessive length of prophylaxis and therapeutic courses, inappropriately broad therapy, and antibiotic use when not indicated on the other. Surgeons must understand the impact of poor antibiotic practices in their patients, both in terms of an inadequate response to therapy for an existing infection and an increased risk of subsequent infectious complications, particularly antibiotic resistant infections. The surgical community has been slow to respond [3,9,10]. On a daily basis, poor compliance on both sides of the antibiotic prescribing equation is common, although frequently unrecognized and undocumented. Restricting the use of these drugs to specialists who are not involved primarily in the patient’s care is a drastic solution that will likely have unintended consequences and can be avoided by education and the adoption of appropriate stewardship. That the Joint Commission on Accreditation of Health Care Organizations is now involved actively, mandating demonstration of education of antimicrobial stewardship by hospitals during their accreditation visits, should not be a surprise. Through the 2017 U.S. Antibiotic Awareness Week (formerly the ‘‘Get Smart About Antibiotics Week’’), the CDC is raising awareness of antibiotic resistance as a serious public health concern that requires action [2]. In their global declaration in this issue, Sartelli et al. have highlighted the extent and implications of antimicrobial resistance, a problem that is compounded by a lack of effective drugs coming down the pipeline. This combination has required that old drugs with suboptimal safety profiles are now administered in combination to fight resistant organisms. The authors also highlight the multi-disciplinary approach that is likely required to maximize stewardship performance and summarize the basic

Inhibitory Effect of Four Probiotics on Escherichia Coli K88 in Vitro

Screening of Novel Probiotics with Intestinal Peristalsis-Promoting Potential Based on in Vitro and in Vivo Investigations

Study on the effects of Clostridium butyricum on pathogen and beneficial bacteria in vitro

Effects of mixed culture of Clostridium butyricum and Lactobacillus rhamnosus on intestinal bacteria in vitro

The Efficacy of Selected Probiotic Strains and Their Combination to Inhibit the Interaction of Adherent-Invasive Escherichia coli (AIEC) with a Co-Culture of Caco-2:HT29-MTX Cells

Inhibitory Effect of Lactococcus and Enterococcus faecalis on Citrobacter Colitis in Mice

The Acid, Bile Tolerance and Antimicrobial Property of Lactobacillus Acidophilus Nit

Safety Evaluation of Bifidobacterium Lactis BL-99 and Lacticaseibacillus Paracasei K56 and ET-22 in Vitro and in Vivo

Screening of Probiotics from Bovine Intestine and Identification of Three Probiotics Strains Bacillus

In vitro Organic Acid Production and In Vivo Food Pathogen Suppression by Probiotic S. thermophilus and L. bulgaricus

A young female case of polyarteritis nodosa strongly suspected by typical angiographic findings which improved rapidly after prednisolone and cyclophosphamide therapy.

The inhibition mechanism of co-cultured probiotics on biofilm formation of Klebsiella pneumoniae

Effect of probiotic bacterial strains of Lactobacillus, Bifidobacterium, and Enterococcus on enteroaggregative Escherichia coli

Several Strains of Lactic Acid Bacteria: Adhesion Ability to Caco-2 Cells and Effects on Adhesion of Pathogenic Bacteria

In Vitro Evaluation of Probiotic Properties and Anti-Pathogenic Effects of Lactobacillus and Bifidobacterium Strains as Potential Probiotics

Antibacterial Action of Selenium-Enriched Probiotics Against Pathogenic Escherichia Coli

Growth and adhesion inhibition of pathogenic bacteria by live and heat-killed food-origin Lactobacillus strains or their supernatants

In vitro evaluation of the antimicrobial activity of a range of probiotics against pathogens: evidence for the effects of organic acids

Evaluation of Lactic Acid Bacteria on the Inhibition of Vibrio parahaemolyticus Infection and Its Application to Food Systems

In Vitro Characterization of Lactobacillus plantarum Strains with Inhibitory Activity on Enteropathogens for Use as Potential Animal Probiotics

Surgical Infection Society: We Endorse Antimicrobial Stewardship We Stand by Our International Colleagues and Societies in the Fight for Proper Antimicrobial Therapy.